What is Neuronetics's gain/loss on asset sales?

Neuronetics (STIM) reported gain/loss on asset sales of -$270K in Q1 2026.

What does gain/loss on asset sales mean?

Gains or losses on asset disposals removed from operating cash flow — the cash impact is captured in investing activities.

Neuronetics STIM Gain/Loss on Asset Sales

Gain/Loss on Asset Sales at other companies

LBR

LB Pharmaceuticals Inc Common StockLBRX

$0-100%

CVRx, Inc.CVRX

-$1K—

Neuropace, Inc.NPCE

$0+100%

Orthofix Medical Inc.OFIX

-$331K-1,224%

Neurocrine BiosciencesNBIX

——

Other financials

Income statement

See full

Revenue$34.5M+7.8%

Gross profit$16.2M+2.6%

Operating income-$9.0M+18.3%

Net income-$10.8M+14.9%

EPS (diluted)-$0.16+23.8%

Balance sheet

See full

Cash & equivalents$13.2M-34.7%

Total debt$85.4M+3.5%

Total equity$13.3M-62.6%

Total assets$125.4M-11.7%

Cash flow

See full

Operating cash flow-$9.4M+44.6%

CapEx$197.0K-10.0%

Free cash flow-$9.6M+44.1%

Valuation

See full

Market cap$90.46M-56.2%

Enterprise value$162.64M-42.0%

P/S0.6×-1.3×

Profitability

See full

Gross margin48%-15.6pp

Operating margin-19.4%-6.9pp

Net margin-24.5%-8.7pp

FCF margin-9.4%-4.1pp

Returns & leverage

See full

Return on equity-152.4%-1.4pp

Debt / equity6.4×+4.1×

Current ratio1.7×-0.8×

Where this comes from

Reported directly by Neuronetics in its filing.

Tagged under the XBRL concept us-gaap:GainLossOnSaleOfPropertyPlantEquipment.

The official record: Neuronetics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Neuronetics's gain/loss on asset sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Neuronetics's gain/loss on asset sales?: Neuronetics (STIM) reported gain/loss on asset sales of -$270K in Q1 2026.
What does gain/loss on asset sales mean?: Gains or losses on asset disposals removed from operating cash flow — the cash impact is captured in investing activities.